Seth Arum

Senior Director, Global Patient Safety and Risk Management at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Seth Arum's Colleagues at Alnylam Pharmaceuticals
Amanda Schmidt

Manager, Marketing Operations & Excellence

Contact Amanda Schmidt

Joseph Barry

Principal Data Scientist

Contact Joseph Barry

Liz Kasmarek

Manager, Launch Project Management

Contact Liz Kasmarek

David Neville

Manager, Global Diagnostics

Contact David Neville

View All Seth Arum's Colleagues
Seth Arum's Contact Details
HQ
(617) 551-8200
Location
Rutland, Massachusetts, United States
Company
Alnylam Pharmaceuticals
Seth Arum's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Seth Arum
Seth Arum currently works for Alnylam Pharmaceuticals.
Seth Arum's role at Alnylam Pharmaceuticals is Senior Director, Global Patient Safety and Risk Management.
Seth Arum's email address is ***@alnylam.com. To view Seth Arum's full email address, please signup to ConnectPlex.
Seth Arum works in the SaaS industry.
Seth Arum's colleagues at Alnylam Pharmaceuticals are Maricarmen Garcia, Amanda Schmidt, Joseph Barry, Danny Trinh, Liz Kasmarek, Jessica Miklosko, David Neville and others.
Seth Arum's phone number is (617) 551-8200
See more information about Seth Arum